Our webinars allow users to learn from experts and earn continuing education credits on industry topics, progress in research, services available, and more.
Date: November 09, 2022 Time: 9:00am (PST), 12:00pm (EST), 6:00pm (CET) Hemoglobin A1c is used clinically as a biomarker for the diagnosis and management of diabetes mellitus. Various method...
In this session, researchers, clinicians, and program implementers from four countries will address the disruption in continuity of care for PLHIV amid the COVID-19 pandemic and the conseque...
Date: November 09, 2022 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CET) The field of cell and gene therapy is rapidly growing. In particular, the use of lentiviruses in CAR-T applications is...
Severe acute respiratory syndrome coronavirus (SARS-CoV-2) is a novel virus that causes COVID-19 and has considerable variability in clinical outcomes among infected patients. The GENCOV stu...
In spite of significant progress in disease diagnosis and treatment, racial and ethnic minorities experience lower quality of care and poorer outcomes for certain conditions than non-minorit...
Inflammatory myopathies are a group of rare diseases that are characterized by progressive muscle weakness due to chronic skeletal muscle inflammation. Classification of these rare diseases...
Rapid genomic surveillance of pathogens can provide valuable insights, in order to guide public health interventions. Novel workflows using nanopore technology enables for real-time sequenci...
Cancer is a heterogeneous but related group of diseases wherein cells in certain tissues of the body proliferate uncontrollably and eventually invade adjacent and distant tissues. The oldest...
The World Health Organization (WHO) classified monkeypox as a zoonosis, that is, a disease that is transmitted from animals to humans. Since early May 2022, many instances of monkeypox have...
Each year, more monoclonal antibodies (mAbs) are approved by regulatory agencies to treat a wide range of diseases with an expected market value of over $200 billion by 2026. The advantage o...
Date: November 08, 2022 Time: 11:00am (PST), 2:00pm (EST), 8:00pm (CET) Developing safe and effective CAR T cell therapies is a challenging task. That’s why thinking translational earl...
Date: November 8, 2022 Time: 1:00pm (SGT), 12:00pm (EST), 6:00am (CET) Antibodies are vital tools in many of the laboratory techniques that are used...
Date: November 3, 2022 Time: 7:00am (PDT), 10:00am (EDT), 4:00pm (CEST) In this webinar, our speakers will provide an introduction into the epidemiology of influenza A/B, RSV, COVID-19, Aden...
Genome engineers can leverage an ever-expanding array of biological and computational tools to make targeted genetic changes. Maintaining and optimizing components ranging from reagent desig...
As we further understand the complexity and diversity of cellular states, it is becoming necessary for a cellular engineering toolbox, consisting of molecular tools that allow control over c...
Nucleic acid analysis is crucial for the diagnostics of infectious diseases such as COVID-19. CRISPR/Cas technology, beyond its broad application in gene editing, features, in this regard, a...
Clustered regularly interspaced short palindromic repeats (CRISPR)–CRISPR-associated protein 13 (Cas13) has been rapidly developed for nucleic-acid-based diagnostics by using its chara...
Date: November 2, 2022 Time: 7:00am (PDT), 10:00pm (EDT), 4:00pm (CEST) As part of the immune response, inflammation plays a vital role in the host defense and is dictated by the balance bet...
Rapid, accurate and frequent detection of the RNA of SARS-CoV-2 and of serological host antibodies to the virus would facilitate the determination of the immune status of individuals who hav...
The COVID-19 pandemic highlights the need for diagnostics that can be rapidly adapted and deployed in a variety of settings. Several SARS-CoV-2 variants have shown worrisome effects on vacci...
The CRISPR revolution has begun and shows no signs of slowing down. CRISPR-Cas nuclease-based genome editing strategies hold great promise for the treatment of genetic disorders. However, a...
CRISPR/Cas gene editing technology has rapidly evolved over the last decade. Its versatility extends from creating targeted research-use disease models in cells and animals, to high-throughp...
Simple and sensitive nucleic acid-based molecular detection plays a crucial role in the early diagnosis of infectious diseases and the rapid screening of cancers. CRISPR technology has recen...
The Cas9 from Francisella novicida (FnCas9) has unique properties of target identification and engagement in terms of specificity, nature of double strand break as well as length of guide RN...
Traditional methods for pathogen detection are often expensive and time-consuming and requires a well-equipped laboratory. Here we present a low-cost, deployable paper-based biosensor device...
My laboratory uses tools from pharmacology, genomics, and cell signaling to study two key aspects of cancer biology. First, we seek to understand how oncogenic signals, altered metabolic sta...
Date: November 09, 2022 Time: 9:00am (PST), 12:00pm (EST), 6:00pm (CET) Hemoglobin A1c is used clinically as a biomarker for the diagnosis and management of diabetes mellitus. Various method...
